Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
Saved in:
| Title: | Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor. |
|---|---|
| Authors: | Langenheim JF; Oncology Research Institute, Greenville Hospital University Medical Center, Greenville, South Carolina 29605-4255, USA., Chen WY |
| Source: | Journal of receptor and signal transduction research [J Recept Signal Transduct Res] 2009; Vol. 29 (2), pp. 107-12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9509432 Publication Model: Print Cited Medium: Internet ISSN: 1532-4281 (Electronic) Linking ISSN: 10799893 NLM ISO Abbreviation: J Recept Signal Transduct Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
